JNJ-73763989
CR109070
Phase 2 small_molecule terminated
Quick answer
JNJ-73763989 for Hepatitis B, Chronic is a Phase 2 program (small_molecule) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janssen Cilag International NV
- Indication
- Hepatitis B, Chronic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated